Marksans Pharma consolidated net profit rises 1.58% in the September 2025 quarter
Sales rise 12.23% to Rs 720.41 crore
Net profit of Marksans Pharma rose 1.58% to Rs 98.25 crore in the quarter ended September 2025 as against Rs 96.72 crore during the previous quarter ended September 2024. Sales rose 12.23% to Rs 720.41 crore in the quarter ended September 2025 as against Rs 641.92 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales720.41641.92 12 OPM %20.0622.87 -PBDT160.25144.11 11 PBT133.33124.60 7 NP98.2596.72 2Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2025 | 7:48 AM IST